← Open Payments lookup

MEGAN SCOTT: Open Payments

NPI 1740924422 · OMAHA, NE. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,200 in 73 payments from 22 companies in 2025. Trend: 2023 $1,574 · 2024 $1,651 · 2025 $1,200

Food & beverage: $1,200
CompanyPaymentsAmount
ABBVIE INC.12$224
Lilly USA, LLC11$146
PFIZER INC.6$102
Novo Nordisk Inc4$78
ViiV Healthcare Company3$71
AstraZeneca Pharmaceuticals LP4$71
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)4$66
Otsuka America Pharmaceutical, Inc.3$66
SANOFI-AVENTIS U.S. LLC3$62
Teva Pharmaceuticals USA, Inc.3$50

Products named: MOUNJARO, REXULTI, VRAYLAR, APRETUDE, CAPLYTA, TZIELD, UBRELVY, Ozempic.

Industry payments across NE — which companies pay providers there.